By analyzing huge amounts of biological data, the use of machine learning accelerates the identification of critical control ...

The pre-IND meeting provided an opportunity for the Company to discuss its Investigational New Drug (IND) development plan and receive FDA guidance on nonclinical and clinical study requirements for ...

Pleco Therapeutics, a clinical-stage biopharmaceutical company developing novel therapies for difficult-to-treat cancers, announces a positive ...

The data to be presented encompasses five of the company’s novel drug candidates: BCR-ABL tyrosine kinase inhibitor olverembatinib (HQP1351), Bcl-2 inhibitor lisaftoclax (APG-2575), FAK/ALK/ROS1 ...

Cellular reprogramming is an intrinsic evolutionary trait to constantly promote adaptations that confer survival advantage.

As our bodies grow, cells proliferate to form tissues, and cells frequently have to be repaired or replaced throughout life..

A growing body of work suggests that cell metabolism — the chemical reactions that provide energy and building materials — ...

为探究 CHI3L1 在结直肠癌（CRC）放疗抗性中的作用，研究发现其可促癌细胞增殖等，为治疗提供新思路。 在癌症治疗的广阔领域中，结直肠癌（Colorectal Cancer，CRC）一直是困扰全球医学界的难题。它作为常见的胃肠道恶性肿瘤，严重威胁着人类的健康。放疗，作为 CRC 综合治疗的重要一环，对于延长患者生存期、降低局部复发率起着关键作用，尤其是在直肠癌的治疗中，其地位更是不可替代。然而 ...

Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch (UTMB), Galveston, Texas 77555, United States ...